October 27, 2022
|Image courtesy of JNM.|
Today Martin Pomper, MD, PhD, professor of radiology and director of the Nuclear Medicine and Molecular Imaging Division at Johns Hopkins University School of Medicine, was named Most Influential Radiology Researcher for 2022 by AuntMinnie. The “Minnies” awards recognize excellence in radiology.
Pomper was recognized for his work in developing 18F DCFPyL, a PET radiotracer that targets prostate-specific membrane antigen (PSMA)–positive lesions in men with prostate cancer. He did his initial work on the tracer in 1996. In the past decade, research on the tracer has been published by Pomper and other influential researchers in The Journal of Nuclear Medicine.
The New Drug Application for the agent was filed in September 2020 and granted priority review by the FDA in December that year. Research supporting the approval of the agent came from two pivotal multicenter studies—the CONDOR study and the OSPREY study. The U.S. Food and Drug Administration approved the radiotracer in May 2021.
SNMMI offers free image interpretation training on 18F-DCFPyL from experienced study investigators covering its mechanism of action, biodistribution, and how to interpret the scans. Access the complimentary 18F-DCFPyL Image Interpretation Training.
The agent is manufactured by Lantheus as Pylarify injection and is widely available throughout the United States.